SCHEMBL23094197

SCHEMBL23094197

Cc1ccc(CC(=O)O/N=C(\N)Cc2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.86

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 7/20 0.86
▸ L3MBTL1 Q9Y468 5/20 0.86
▸ TP53 P04637 1/20 0.78
▸ LMNA P02545 3/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ MAPT P10636 3/20 0.58
▸ HSP90AA1 P07900 2/20 0.58
▸ POLB P06746 1/20 0.58
▸ RECQL P46063 1/20 0.58
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.52
▸ HTT P42858 1/20 0.52
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23094309 0.92 TDP1 (1.00) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094291 0.88 TP53 (1.00) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094230 0.85 L3MBTL1 (0.76) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL21467963 0.79 MAPT (0.56) TDP1L3MBTL1TP53LMNASMN1; SMN2
SCHEMBL23094241 0.78 TP53 (0.69) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094249 0.78 TDP1 (0.75) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094219 0.76 L3MBTL1 (1.00) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094195 0.76 TDP1 (0.72) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094272 0.76 TDP1 (0.77) TDP1L3MBTL1TP53LMNAMAPK1
SCHEMBL23094256 0.75 TDP1 (0.79) TDP1L3MBTL1TP53LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 TDP1 4664/4885L3MBTL1 2077/4885TP53 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback